Abstract Bacillus Calmette-Guérin (BCG) has been in use for nearly 100 years and is the
only licensed TB vaccine. While BCG provides protection against disseminated TB in infants …

Currently, there is only one licensed vaccine against tuberculosis (TB), the Bacillus Calmette–
Guérin (BCG). Despite its protective efficacy against TB in children, BCG has failed to protect …

Tuberculosis (TB) is the leading cause of death worldwide due to an infectious disease,
causing around 1.6 million deaths each year. This situation has become more complicated …

Tuberculosis (TB) is the leading killer among all infectious diseases worldwide despite
extensive use of the Mycobacterium bovis bacille Calmette-Guérin (BCG) vaccine. A safer …

The tuberculosis (TB) pandemic continues to rampage despite widespread use of the BCG
(Bacillus Calmette–Guérin) vaccine. Novel vaccination strategies are urgently needed to …

Tuberculosis (TB) is an important infectious disease worldwide. Currently, Bacillus Calmette‐
Guérin (BCG) remains the only TB vaccine licensed for human use. This TB vaccine is …

A new and improved vaccine against tuberculosis (TB) would provide a powerful tool to
conquer one of the most insidious infectious diseases of mankind. Protection afforded by …

Effective prophylactic and/or therapeutic vaccination is a key strategy for controlling the
global TB epidemic. The partial effectiveness of the existing TB vaccine, bacille Calmette …

The clinical, social, and economic burden of tuberculosis (TB) remains high worldwide,
thereby highlighting the importance of TB prevention. The bacilli Calmette-Guérin (BCG) …

In this review we discuss recent progress in the development, testing, and clinical evaluation
of new vaccines against tuberculosis (TB). Over the last 20 years, tremendous progress has …